Investor profile
Apollo Health Ventures has backed 4 European tech companies across 4 funding rounds between 2022 and 2025, joining rounds totalling €80M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| haya therapeutics | Switzerland | 1 | €58M |
| Scripta Therapeutics | UK | 1 | €10M |
| Refoxy Pharmaceuticals | Germany | 1 | €9.1M |
| Cleara Biotech B.V. | Netherlands | 1 | €2.6M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| haya therapeutics | Series A | €58M | 2025-05 |
| Scripta Therapeutics | Seed | €10M | 2025-11 |
| Refoxy Pharmaceuticals | Seed | €9.1M | 2024-12 |
| Cleara Biotech B.V. |
| Seed |
| €2.6M |
| 2022-09 |
